Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank20
3Y CAGR-20.2%
5Y CAGR-16.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-20.2%/yr
vs -0.4%/yr prior
5Y CAGR
-16.6%/yr
Recent deceleration
Acceleration
-19.8pp
Decelerating
Percentile
P20
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $86.38M | +6.6% |
| 2022 | $81.02M | -45.1% |
| 2021 | $147.70M | -13.0% |
| 2020 | $169.73M | +20.6% |
| 2019 | $140.70M | -34.2% |
| 2018 | $213.75M | +20.2% |
| 2017 | $177.81M | +3.2% |
| 2016 | $172.23M | -1.9% |
| 2015 | $175.60M | -8.2% |
| 2014 | $191.36M | - |